BiochemProbe — Life Science Research Reagents

Gemigliptin free base · Synonyms: LC15-0444

Gemigliptin is a highly selective, reversible and competitive dipeptidyl peptidase-4 inhibitor.

For research use only. Not for human or veterinary use.

Purity >98% Stock Inquire

Gemigliptin structure

CAS No.: 911637-19-9

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
1 g USD 688.00 BP-00061-1g In stock Get quote
5 g USD 2,100.00 BP-00061-5g In stock Get quote

Description

Gemigliptin (LC15-0444 ) is a highly selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4.

Biological activity

In Vitro Gemigliptin dose-dependently inhibits the formation of AGE-BSA with IC50 of 11.69 mM[1]. Gemigliptin dose-dependently suppressed the cross-linking of preformed AGE-BSA with rat tail tendon collagen with an IC50 of 1.39 mM[1]. Gemigliptin is a competitive inhibitor with a Ki of 7.25 nM[2]. In Vivo Gemigliptin (100 mg/kg; i.g.; daily; for 12 weeks) inhibits AGEs formation and AGE cross-links in vivo[1]. Gemigliptin dose-dependently inhibits plasma DPP-4 activity in rats, dogs, and monkeys[2].

Specifications

MW (average)
489.3630
Formula
C18H19F8N5O2
CAS No.
911637-19-9
Physical state
Solid
Color
white to orange
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 2 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO

References

[1]. Jung E, et al. Gemigliptin, a novel dipeptidyl peptidase-4 inhibitor, exhibits potent anti-glycation properties in vitro and in vivo. Eur J Pharmacol. 2014 Dec 5;744:98-102.
[2]. Kim SH, et al. Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo. Eur J Pharmacol. 2016 Oct 5;788:54-64.